NIRxcell, our fifth generation coronary stent, was designed for superior deliverability and demonstrated outstanding clinical outcomes (5.1% TLR at 9 months). Flexx² catheter technology with an innovative spring tip provides NIRxcell an unmatched ease-of-delivery in challenging anatomies. Low footprint cobalt-chromium design ensures excellent conformability in curved sections and best-in-class scaffolding while preventing tissue prolapse more...
The first elastomeric Drug-Eluting Stent demonstrated outstanding clinical outcomes in two randomized studies on over 2,200 patients, including 5.4% TLR and excellent safety profile at 12 months. Flexx² catheter technology with an innovative spring tip provides EluNIR unmatched ease-of-delivery in challenging anatomies. Low footprint cobalt-chromium design ensures excellent conformability in curved sections and best-in-class scaffolding while preventing tissue prolapse. A unique coating technology ensures long-term surface integrity and programmed elution of limus drug more...
Setting a new standard in biliary stenting performance and leveraging on Medinol's stent design excellence, X-suit NIR and X-suit NIR Covered use variable strut width to enhance conformability, optimize coverage of the bile duct and provide outstanding radial support. Distributed by Olympus Medical more...
Medinol cardiovascular intervention solutions are manufactured in our proprietary FDA-registered manufacturing facility
Our stent design provides high conformability and excellent scaffolding integrity even in curved sections and during myocardial contractions
A game-changer in deliverability, Flexx² catheter technology uses an innovative spring tip that is flexible and pushable at the same time
The next step in DES evolution, a smooth elastomeric coating designed to eliminate irreg ularities and deformations in stent surface
